Balancing Innovation, Evidence and Clinical Expectation
In healthcare, hope can outpace reality, especially when new breakthroughs are shared before they become standard practice.
Public relations can help manage that tension by communicating promising advances to audiences who need to understand them while making clear what is proven, emerging, and may take time to reach clinical care. Done well, this approach builds awareness without inflating expectations, helping a company’s innovation earn attention and still preserve public trust.
When I was diagnosed with early-stage breast cancer in 2025, I became immersed in treatment options—surgery, chemotherapy, radiation, and medication to prevent recurrence. Like most people in that position, I hoped for the least disruptive path forward. Before meeting my oncologist, I read a New York Times article suggesting that many women with intermediate-risk, early-stage breast cancer could safely skip radiation with similar survival rates.
When I asked my doctor to reconsider radiation, she explained that medicine does not move at the pace of media coverage. Promising findings become standards of care only after they are repeatedly validated over time.
The article—and my reaction—reflect a communications issue. My treatment plan reflected established practice. So far ahead of its time, the article left me disappointed, feeling like my care was lacking. It underscored the responsibility healthcare companies and communicators carry when presenting medical innovation.
Communications must present innovation, while also helping audiences balance legitimate excitement and expectations with clinical reality.
When visibility moves faster than validation
Healthcare innovation almost always enters public conversation before it reaches routine clinical use. That gap is driven by a mix of factors, including the need to build awareness, attract investment and partnerships, establish leadership as a first mover in emerging areas, and generate early support.
One clear example of the tension between awareness and the delay of clinical adoption is Stanton’s work with Paige, an AI company focused on advancing cancer diagnostics. Paige’s goal was to attract teaching hospitals as early adopters, establish itself as a pioneer in digital pathology, and position the company for scale through acquisition by a larger industry leader. Their technology was not in mainstream clinical use.
Our communications strategy for Paige was designed to build authority and awareness while keeping the company’s story connected to the state of the evidence and the status of their technology roll out. The program included thought leadership, executive content, media relations, newsjacking, podcast outreach, and a speaking program.
The company earned significant attention across healthcare, consumer, and business media, including Fierce Healthcare, CNN, CNBC and Fox News, with coverage focused on the promise of AI-enabled cancer detection. That visibility helped Paige strengthen its position as a category-defining player in healthcare AI and contributed to its path toward acquisition.
Importantly, that attention was calibrated to where the science actually was. Effective healthcare PR is not simply about increasing visibility, but also about aligning visibility with evidence, adoption timelines, and the decisions clinicians and patients may make based on what they hear.
Communicating innovation that is still evolving
Early-stage innovation often involves academic partnerships, hospital-based studies, and preliminary clinical data, which can signal meaningful progress, but do not yet define standards of care. In these environments, communication works best when it reflects trajectory rather than completion.
In practice, that means companies and communicators must:
- Ground claims in evidence appropriate to the stage of development
- Set expectations around timing and availability
- Translate complexity without diminishing scientific integrity
- Position innovation within the broader care pathway
- Maintain a tone that reflects the emotional reality of healthcare decisions
This discipline strengthens momentum by ensuring that what reaches clinicians, patients, investors, and the public remains aligned with clinical reality as it evolves.
When communication is precise, trust becomes more durable over time—and innovation is understood in line with clinical reality. That level of precision requires sound judgment and a clear roadmap from where the science stands, how clinical adoption may unfold, and what patients, physicians, partners, and the public are likely to do with the information once it reaches them.
Experienced healthcare communicators play an important role here. They help shape how innovation enters the public conversation, make it visible to the right audiences, and ensure that what is said externally balances hope, reality and expectation. Done well, this keeps innovation in step with the evidence, helps expectations stay aligned with what the evidence can support, and allows trust to build over time.
By Cindi Goodsell, Vice President at Stanton.